Fabio Serpenti - Publications

Danazol treatment for poor graft function after hematopoietic stem cell transplantation: a single centre experience.

Journal: Bone marrow transplantation

Published: August 02, 2025

Dramatic endoscopic presentation of Ileal HHV-6 enteritis in a patient treated for graft-versus-host disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 04, 2025

GVHD in the era of checkpoint inhibition in Hodgkin lymphoma.

Journal: Blood advances

Published: January 14, 2025

Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel.

Journal: Blood cancer journal

Published: August 21, 2024

Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.

Journal: Journal of hematology & oncology

Published: July 22, 2024

Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.

Journal: Hematological oncology

Published: April 29, 2024

Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy.

Journal: Mediterranean journal of hematology and infectious diseases

Published: September 02, 2023

Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience.

Journal: Bone marrow transplantation

Published: May 14, 2023

Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients.

Journal: Transplantation and cellular therapy

Published: April 10, 2023

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia.

Journal: Frontiers in oncology

Published: January 21, 2023

Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features.

Journal: Blood transfusion = Trasfusione del sangue

Published: August 08, 2022

Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse.

Journal: Leukemia & lymphoma

Published: June 22, 2022